FIELD: organic chemistry.
SUBSTANCE: invention relates to N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide or its pharmaceutically acceptable salt.
EFFECT: obtaining a novel heterocyclic compound which is a bromodomain (BET) inhibitor which is selective with respect to binding domain II (BDII).
2 cl, 2 tbl, 129 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2646754C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
COMPOUND BASED ON PYRROLAMIDOPYRIDONE, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2809596C2 |
COMPOUND FOR DESTRUCTION OF ANDROGEN RECEPTOR AND ITS PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2817356C1 |
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
ENZYME INHIBITORS | 2014 |
|
RU2674028C2 |
Authors
Dates
2021-01-28—Published
2017-04-14—Filed